Literature DB >> 7143242

Transport and metabolism of [3H]morphine in isolated, nonperfused proximal tubular segments of the rabbit kidney.

C Schäli, F Roch-Ramel.   

Abstract

Proximal tubular segments (S1, S2 and S3) of the rabbit kidney were incubated in oxygenated Ringer's solution (30 min, pH 7.4, 37 degrees C) containing bovine serum albumin (10 g/l) and [3H]morphine (0.7 microM). The uptake, expressed as tissue water/medium ratio at equilibrium, for S1 was 42.2 +/- 3.95 (mean +/- S.E.), n = 16 tubules from six animals; for S2, 41.6 +/- 4.17, n = 18 tubules from six animals; and for S3, 29.0 +/- 3.83, n = 15 tubules from six animals, a value significantly lower (P less than .05) than in the S1 and S2 segment. High-performance liquid chromatography analysis of the accumulated tritium revealed metabolism of [3H]morphine. Unchanged morphine represented 35.5 +/- 3.4% of the total radioactivity recovered in the extract from S1 segments, 51.1 +/- 7.7% from S2 and 77.3 +/- 1.8 from S3 segments. After treating the tubular extracts with beta-glucuronidase (5 hr, 25 degrees C), all the recovered radioactivity represented unchanged morphine. The main metabolite, thus, was a glucuronide. KCN (10(-2) M), mepiperphenidol (Darstine, 10(-4) M) and quinine (10(-4) M) inhibited [3H]morphine uptake by 55-70%. Surprisingly, there was no decrease in uptake in the presence of N1-methylnicotinamide (10(-3) M). We conclude that the whole proximal tubule is able to accumulate morphine by a specific transport system for organic cations, but that part of this uptake might be due to cellular metabolism and intracellular binding of the drug.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7143242

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  9 in total

1.  The influence of moderate hypoalbuminaemia on the renal metabolism and dynamics of furosemide in the rabbit.

Authors:  V Pichette; D Geadah; P du Souich
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

2.  Hepatic extraction of morphine is impaired in cirrhosis.

Authors:  B Crotty; K J Watson; P V Desmond; M L Mashford; L J Wood; J Colman; F J Dudley
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  Metabolism of narcotics.

Authors:  H McQuay; A Moore
Journal:  Br Med J (Clin Res Ed)       Date:  1984-01-21

Review 4.  Cholestasis and endogenous opioids: liver disease and exogenous opioid pharmacokinetics.

Authors:  Mellar Davis
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 5.  High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.

Authors:  J Säwe
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

6.  Dihydrocodeine in renal failure: further evidence for an important role of the kidney in the handling of opioid drugs.

Authors:  J N Barnes; A J Williams; M J Tomson; P A Toseland; F J Goodwin
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-09

7.  Plasma concentrations and renal clearance of morphine, morphine-3-glucuronide and morphine-6-glucuronide in cancer patients receiving morphine.

Authors:  A A Somogyi; R L Nation; C Olweny; P Tsirgiotis; J van Crugten; R W Milne; J F Cleary; C Danz; F Bochner
Journal:  Clin Pharmacokinet       Date:  1993-05       Impact factor: 6.447

8.  Transport of organic cations in brush border membrane vesicles from rabbit kidney cortex.

Authors:  C Rafizadeh; M Manganel; F Roch-Ramel; C Schäli
Journal:  Pflugers Arch       Date:  1986-10       Impact factor: 3.657

9.  Morphine: pharmacokinetics and clinical practice.

Authors:  P J Hoskin; G W Hanks
Journal:  Br J Cancer       Date:  1990-11       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.